Opal Wealth Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$223K Buy
4,619
+188
+4% +$8.77K 0.05% 190
2025
Q4
$215K Sell
4,431
-286
-6% -$14.2K 0.06% 192
2025
Q3
$223K Sell
4,717
-1,426
-23% -$68.8K 0.06% 177
2025
Q2
$297K Buy
6,143
+718
+13% +$36.7K 0.08% 141
2025
Q1
$301K Buy
5,425
+331
+6% +$17.9K 0.09% 121
2024
Q4
$246K Sell
5,094
-33
-0.6% -$1.68K 0.07% 152
2024
Q3
$295K Buy
5,127
+538
+12% +$29K 0.09% 126
2024
Q2
$223K Buy
+4,589
New +$221K 0.07% 158

Other funds holding SNY

Opal Wealth Advisors's SNY Position: Q1 2026 in Review

Opal Wealth Advisors increased its Sanofi (SNY) stake by 4.2% in Q1 2026, buying an estimated $8.77K and bringing the position to 4,619 shares worth $223K. The position accounts for 0.05% of the portfolio, ranked #190.

Opal Wealth Advisors first reported a position in SNY in Q2 2024 and has held it in 8 quarters since. The position peaked at $301K in Q1 2025. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Opal Wealth Advisors held 4,619 shares of Sanofi worth $223K as of Q1 2026.
  • Opal Wealth Advisors bought 188 Sanofi shares in Q1 2026, an estimated $8.77K.
  • Sanofi made up 0.05% of Opal Wealth Advisors's portfolio in Q1 2026, its #190 holding.
  • Opal Wealth Advisors first reported a position in Sanofi in Q2 2024 and has held it in 8 quarters since.
  • Opal Wealth Advisors's Sanofi position peaked at $301K in Q1 2025.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Opal Wealth Advisors's 13F filing for Q1 2026, filed 14 Apr 2026.